Drug Type Stem cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Neoprogen, Inc.Startup |
Active Organization- |
Inactive Organization Neoprogen, Inc.Startup |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Dilated | Phase 1 | US | Neoprogen, Inc.Startup | 19 Dec 2021 |
Heart Failure | Phase 1 | US | Neoprogen, Inc.Startup | 19 Dec 2021 |